Eun Sil Yu
Overview
Explore the profile of Eun Sil Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahn Y, Yun S, Lee S, Son J, Jo S, Byun J, et al.
Korean J Radiol
. 2020 Mar;
21(4):413-421.
PMID: 32193889
Objective: A widely applicable, non-invasive screening method for non-alcoholic fatty liver disease (NAFLD) is needed. We aimed to develop and validate an index combining computed tomography (CT) and routine clinical...
2.
Jang J, Kim K, Choi S, Jeong S, Kim J, Yu E, et al.
Eur Radiol
. 2019 Feb;
29(7):3736-3745.
PMID: 30707276
Purpose: This study was conducted in order to investigate computed tomography (CT) findings associated with acute cellular rejection (ACR) following liver transplantation (LT) and their relevance to clinical outcomes. Materials...
3.
Byun J, Lee S, Sung Y, Shin Y, Yun J, Kim H, et al.
Eur Radiol
. 2018 Dec;
29(8):4427-4435.
PMID: 30569183
Objectives: To compare the performances of CT indices for diagnosing hepatic steatosis (HS) and to determine and validate the CT index cut-off values. Methods: Three indices were measured on non-enhanced...
4.
Choi K, Jang J, Lee S, Sung Y, Shim W, Kim H, et al.
Radiology
. 2018 Sep;
289(3):688-697.
PMID: 30179104
Purpose To develop and validate a deep learning system (DLS) for staging liver fibrosis by using CT images in the liver. Materials and Methods DLS for CT-based staging of liver...
5.
Kim J, Choi G, Jung Y, Kim K, Jang S, Yu E, et al.
J Cancer Res Clin Oncol
. 2018 Jun;
144(8):1487-1501.
PMID: 29858683
Purpose: Although sorafenib enhances overall survival, sorafenib resistance has been reported to be a significant limiting factor for improved prognosis in patients with hepatocellular carcinoma (HCC). Therefore, it is important...
6.
Jung D, Hwang S, Song G, Ahn C, Moon D, Kim K, et al.
Ann Transplant
. 2017 Jan;
22:42-52.
PMID: 28123170
BACKGROUND Intrahepatic cholangiocarcinoma (ICC) can be incidentally diagnosed after liver transplantation (LT). We investigated the clinicopathological features of LT recipients with ICC and compared prognosis with that of the control...
7.
Jung D, Hwang S, Song G, Ahn C, Moon D, Kim K, et al.
Liver Transpl
. 2016 Dec;
23(3):330-341.
PMID: 28027599
Combined hepatocellular carcinoma-cholangiocarcinoma (cHCC-CC) is a rare disease. We investigated the clinicopathological features of cHCC-CC and compared the longterm outcomes following liver transplantation (LT) and hepatic resection (HR). We identified...
8.
Jung D, Hwang S, Hong S, Chung Y, Song G, Lee Y, et al.
World J Surg
. 2016 Nov;
41(5):1347-1357.
PMID: 27896409
Background: Combined hepatocellular carcinoma and cholangiocarcinoma (cHC) has wide histological diversity. We intended to investigate the prognostic influence of tumor types of cHC. Methods: We analyzed the clinical and pathological...
9.
Jung D, Hwang S, Kim K, Hong S, Lee Y, Ahn C, et al.
World J Surg
. 2016 Nov;
41(3):825-834.
PMID: 27812807
Background: Simultaneous double primary hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) (dpHCC-ICC) is very rare. This study investigated the clinicopathological features and post-resection prognosis of dpHCC-ICC. Methods: We identified 10...
10.
Park Y, Kim D, Koo H, Jang S, You Y, Cho J, et al.
Oncotarget
. 2016 Jun;
7(30):48155-48167.
PMID: 27340866
Pyruvate kinase muscle type 2 (PKM2) exhibits post-translational modifications in response to various signals from the tumor microenvironment. Insulin-like growth factor 1 (IGF-1) is a crucial signal in the tumor...